Top of the Street: Hensoldt, Unilever, Evonik, dsm-firmenich, IMCD, AAK

By Reuters News

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** J.P. Morgan upgrades German defence electronics maker Hensoldt HAGG.DE to "overweight" from "neutral"; says it has among the most attractive product portfolios in the European defence sector and has made required investments to facilitate strong sales

** Deutsche Bank raises British consumer goods giant Unilever ULVR.L to "buy" from "hold"; says company offers a balance of transformation potential, earnings confidence and liquidity benefits to hedge AI risk in a balanced portfolio

** Jefferies cuts Germany's Evonik Industries EVKn.DE to "hold" from "buy"; sees earnings improvement in 2026 as temporary rather than structural

** Jefferies downgrades European chemicals maker dsm-firmenich DSFIR.AS to "hold" from "buy"; views current valuation multiple as full

** Jefferies cuts Dutch ingredients maker IMCD IMCD.AS to "hold"; sees moderate return to organic growth, supporting broadly stable gross margins and a gradual recovery in conversion and EBITA margins

INITIATIONS AND REINSTATEMENTS

** Jefferies initiates Swedish plant-based oils and fats maker AAK with "hold" rating; says weak volumes and pricing pressure weigh on near-term earnings

(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk